PAX Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$575K Sell
2,351
-109
-4% -$25.4K 0.1% 107
2025
Q4
$509K Sell
2,460
-31
-1% -$6.13K 0.09% 121
2025
Q3
$462K Sell
2,491
-188
-7% -$32.2K 0.08% 147
2025
Q2
$409K Sell
2,679
-1,731
-39% -$266K 0.08% 165
2025
Q1
$731K Sell
4,410
-82
-2% -$12.8K 0.13% 128
2024
Q4
$650K Buy
4,492
+103
+2% +$16K 0.12% 146
2024
Q3
$711K Buy
4,389
+162
+4% +$25.8K 0.13% 142
2024
Q2
$618K Buy
4,227
+359
+9% +$53.4K 0.12% 148
2024
Q1
$612K Buy
3,868
+12
+0.3% +$1.91K 0.12% 161
2023
Q4
$603K Buy
3,856
+146
+4% +$22.4K 0.12% 161
2023
Q3
$578K Sell
3,710
-77
-2% -$12.7K 0.13% 143
2023
Q2
$627K Buy
3,787
+23
+0.6% +$3.71K 0.14% 130
2023
Q1
$583K Sell
3,764
-94
-2% -$15.2K 0.14% 120
2022
Q4
$682K Sell
3,858
-554
-13% -$95.7K 0.17% 98
2022
Q3
$721K Sell
4,412
-75
-2% -$12.7K 0.18% 89
2022
Q2
$796K Sell
4,487
-1,285
-22% -$229K 0.2% 75
2022
Q1
$1.02M Sell
5,772
-46
-0.8% -$7.83K 0.24% 63
2021
Q4
$995K Buy
5,818
+234
+4% +$38.3K 0.22% 68
2021
Q3
$902K Buy
5,584
+20
+0.4% +$3.41K 0.22% 64
2021
Q2
$917K Buy
5,564
+374
+7% +$61.9K 0.23% 56
2021
Q1
$853K Buy
5,190
+799
+18% +$129K 0.24% 52
2020
Q4
$691K Buy
4,391
+99
+2% +$14.6K 0.22% 51
2020
Q3
$639K Buy
4,292
+430
+11% +$63.6K 0.22% 47
2020
Q2
$543K Buy
3,862
+356
+10% +$51.9K 0.21% 47
2020
Q1
$543K Buy
3,506
+769
+28% +$109K 0.23% 46
2019
Q4
$408K Buy
+2,737
New +$371K 0.17% 61

Other funds holding JNJ

PAX Financial Group's JNJ Position: Q1 2026 in Review

PAX Financial Group reduced its Johnson & Johnson (JNJ) stake by 4.4% in Q1 2026, selling an estimated $25.4K and leaving 2,351 shares worth $575K. The position accounts for 0.1% of the portfolio, ranked #107.

PAX Financial Group first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.02M in Q1 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • PAX Financial Group held 2,351 shares of Johnson & Johnson worth $575K as of Q1 2026.
  • PAX Financial Group sold 109 Johnson & Johnson shares in Q1 2026, an estimated $25.4K.
  • Johnson & Johnson made up 0.1% of PAX Financial Group's portfolio in Q1 2026, its #107 holding.
  • PAX Financial Group first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • PAX Financial Group's Johnson & Johnson position peaked at $1.02M in Q1 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on PAX Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.